secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001628280-26-013553
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Critical Medical Q4 revenue up 83.5% YoY to $66.8M; raises FY2026 guidance
--------------------------------------------------------------------------------

- Q4 2025 revenue $66.8M (+83.5% YoY); logistics revenue up 35.3% to $49.2M.
- Full year 2025 revenue $197.1M, Adjusted EBITDA $14.1M, both above guidance high end.
- Full year 2025 net loss from continuing ops $20.1M vs $16.1M in 2024.
- FY2026 revenue guidance raised to $260-275M; Adjusted EBITDA guidance raised to $29-33M.
- Clinical segment (Keystone) contributed $17.6M revenue in Q4; total gross profit $14.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/0001628280-26-013553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/srta-20260303.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-013553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer